Sino Biopharmaceutical (SBMFF)
(Delayed Data from OTC)
$0.47 USD
+0.04 (9.92%)
Updated Sep 26, 2024 09:33 AM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
SBMFF 0.47 +0.04(9.92%)
Will SBMFF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SBMFF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for SBMFF
Sino Biopharmaceutical’s Promising Cancer Drug Results
Sino Biopharm Unveils Promising Cancer Drug Results
Sino Biopharmaceutical’s Breakthrough in Liver Cancer Treatment
Sino Biopharmaceutical Unveils Respiratory Drug Breakthroughs
Sino Biopharmaceutical: Strong Performance Justifies Buy Rating